First-Manhattan-Co

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
678
Total Value
34278225035
Accession Number
0001750312-25-000007
Form Type
13F-HR
Manager Name
First-Manhattan-Co
Data Enrichment
91% identified
618 identified60 unidentified

Holdings

678 positions • $34.3B total value
Manager:
Search and click to pin securities to the top
Page 34 of 34
Evolv Technologies Holdings, Inc.
Shares:28.5K
Value:$88.8K
% of Portfolio:0.0% ($88.8K/$34.3B)
Valens Semiconductor Ltd.
Shares:43.5K
Value:$88.7K
% of Portfolio:0.0% ($88.7K/$34.3B)
OPKO HEALTH, INC.
Shares:51.8K
Value:$85.9K
% of Portfolio:0.0% ($85.9K/$34.3B)
PATTERSON UTI ENERGY INC
Shares:10.4K
Value:$85.8K
% of Portfolio:0.0% ($85.8K/$34.3B)
abrdn Income Credit Strategies Fund
Shares:13.7K
Value:$80.8K
% of Portfolio:0.0% ($80.8K/$34.3B)
CERUS CORP
Shares:57.0K
Value:$79.2K
% of Portfolio:0.0% ($79.2K/$34.3B)
Calamos Global Dynamic Income Fund
Shares:10.5K
Value:$67.2K
% of Portfolio:0.0% ($67.2K/$34.3B)
Immuneering Corp
Shares:32.3K
Value:$49.1K
% of Portfolio:0.0% ($49.1K/$34.3B)
Arbutus Biopharma Corp
Shares:14.0K
Value:$48.9K
% of Portfolio:0.0% ($48.9K/$34.3B)
Zevia PBC
Shares:22.0K
Value:$47.5K
% of Portfolio:0.0% ($47.5K/$34.3B)
NEUBERGER BERMAN REAL ESTATE SECURITIES INCOME FUND INC
Shares:14.1K
Value:$46.5K
% of Portfolio:0.0% ($46.5K/$34.3B)
Taysha Gene Therapies, Inc.
Shares:28.5K
Value:$39.6K
% of Portfolio:0.0% ($39.6K/$34.3B)
CalciMedica, Inc.
Shares:13.2K
Value:$25.3K
% of Portfolio:0.0% ($25.3K/$34.3B)
60800C208
Shares:26.4K
Value:$22.4K
% of Portfolio:0.0% ($22.4K/$34.3B)
Lucid Diagnostics Inc.
Shares:12.6K
Value:$18.8K
% of Portfolio:0.0% ($18.8K/$34.3B)
PDS Biotechnology Corp
Shares:15.0K
Value:$17.9K
% of Portfolio:0.0% ($17.9K/$34.3B)
Grove Collaborative Holdings, Inc.
Shares:11.7K
Value:$15.7K
% of Portfolio:0.0% ($15.7K/$34.3B)
Ovid Therapeutics Inc.
Shares:26.0K
Value:$8.1K
% of Portfolio:0.0% ($8.1K/$34.3B)